Table 2 Multivariate Cox Proportional Hazards models of survival adjusted for age.

From: Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis

Variable

Hazard Ratio

95% CI

p Value

lower

upper

Sex, male

0.231

0.047

1.125

ns.

Smoking pack years

0.985

0.967

1.004

ns.

Minimum SpO2 in 6MWT before AE*, %

0.932

0.866

1.003

ns.

JRS severity grade before AE*

1.610

1.023

1.535

0.040

Preceding oxygen therapy, +

2.628

1.072

6.440

0.035

Serum adiponectin, ng/mL

1.000

1.000

1.000

ns.

Serum leptin, ng/mL

0.927

0.855

1.005

ns.

Adiponectin/leptin ratio

1.000

1.000

1.000

0.012

Adiponectin/leptin ratio, ≥905

2.600

1.031

6.558

0.042

Peripheral blood neutrophils at AE, /μL

1.000

1.000

1.000

0.020

Serum KL-6 at AE, U/mL

1.000

0.999

1.000

ns.

P/F ratio at AE

0.996

0.992

1.001

ns.

Period from admission to the beginning of AE treatment, days

1.125

1.008

1.255

0.035

  1. *Pulmonary function tests, severity scores, HRCT, and serum markers were evaluated within 12 months before AE-IPF.
  2. Abbreviations; SpO2: partial oxygen saturation, 6MWT: 6-minute walk test, AE: acute exacerbation, JRS: Japanese respiratory society, KL-6: Krebs von den Lungen-6, P/F: PaO2/FiO2, ns.: not significant.